Get started

Unitedhealth

UNH | UnitedHealth Group (UNH) | BearishNYSE:UNH Technical Analysis of UnitedHealth Group (UNH) Key Observations: Current Price Action: Price: $498.50 Recent Drop: -21.98 (-4.22%) Support and Resistance Levels: Immediate Support: $475.87 (Target Price 1) Further Supports: $436.72 (Target Price 2) Resistance: The price recently broke below previous support around $525-$530, confirming bearish momentum. Trendlines: The price has clearly broken below a key upward trendline. The breakdown signals a shift from a bullish to a bearish trend, with lower highs (LH) and lower lows (LL) forming. Relative Strength Index (RSI): Current RSI: Below 30 (Oversold Zone). The RSI indicates heavy selling pressure, suggesting the stock may be oversold, but bearish momentum remains intact. Target Prices: Target Price 1: $475.87 This level acts as immediate support where price could pause or consolidate. Target Price 2: $436.72 If the price breaches the $475.87 level, the next key support lies at $436.72. Summary: UnitedHealth Group (UNH) is showing clear bearish signs, having broken below critical support and its upward trendline. The RSI indicates an oversold condition, but momentum remains downward. Key levels to monitor are $475.87 (Target 1) and $436.72 (Target 2). Any recovery will need to overcome resistance at $525-$530 for a trend reversal.
NYSE:UNHShort
by shkspr
UNH Selloff Unreasonable - Still 15% ROI Short-TermSince my first NYSE:UNH idea a couple of days ago the price of this stock dropped significantly. If you've been part of the first idea you should've been able to lock in around 1.x% of return when using a tight stop-loss. Otherwise you've been stopped out with break-even. Nevertheless, the sell-off was not helpful and is completely exaggerating the situation at UNH since the company is not really effected by the current PBM debate. "Deutsche Bank sees a potential divestiture as not having a significant impact on earnings, estimating the risk at likely less than $200M of the company’s roughly $30B+ operating earnings. Deutsche Bank noted, however, that CVS (CVS), Cigna (CI) and UnitedHealth (NYSE:UNH) 'could face additional risk from losing the ability to vertically integrate the PBM, fulfillment and manufacturing functions of biosimilars through organizations like Cordavis and Quallent.' Despite concerns about the potential breakup of their pharmacy businesses, Deutsche Bank maintained it's buy rating on UnitedHealth (UNH)." From a technical standpoint we can see a confluence of support: Weekly SMA200 Strong Trendline from March 2020 Horizontal Support at $480 UNH managed to bounce from the trendline intraday today. This could mean we're going to see a turnaround from here. If we break below the trendline on the daily chart this trade will be invalidated. Otherwise our target sits at $550.
NYSE:UNHLong
by LGNDRY-Capital
1
UNITEDHEALTH GROUP | THE BEAR'S CLAIM: $UNH PAYS THE PRICE Dec17UNITEDHEALTH GROUP | THE BEAR'S CLAIM: NYSE:UNH PAYS THE PRICE Dec17 UnitedHealth Group, NYSE:UNH , UNH NYSE:UNH Trends: NYSE:UNH Weekly Trend: Bearish NYSE:UNH Daily Trend: Bearish NYSE:UNH 4H Trend: Bearish NYSE:UNH 1H Trend: Bearish NYSE:UNH Price Target Areas: NYSE:UNH BUY/LONG ZONE (GREEN): $488.75 - $514.75 NYSE:UNH DO NOT TRADE/DNT ZONE (WHITE): $480.00 - $488.75 NYSE:UNH SELL/SHORT ZONE (RED): $455.00 - $480.00 All indicators are pointing to bearish for $UNH. Looking at the monthly timeframe we can see there is a range that was respected between the levels of 480 up to 555. After price finally broke the level of 555 a new range began. 560 up to 615/620 area. Given the recent news and events; the stock has since seen a deep bearish trend. Momentum has taken price all the way back down to the previous range low of 480. Price currently rests on 480. Bears should seek continuation and target levels of 455/460, or even down to 415. Bulls should look for a reversal marked by breaks over 488.75 on the lower timeframes, or the 549 area for a higher frame reversal. This is what I would personally look at before entering trades, everything is subject to change on a daily basis and as I analyze different timeframes and ideas. ENTERTAINMENT PURPOSES ONLY, NOT FINANCIAL ADVICE! trendanalysis, trendtrading, priceaction, priceactiontrading, technicalindicators, supportandresistance, rangebreakout, rangebreakdown, rangetrading, chartpatterntrading, chartpatterns, unh, unitedhealth, unitedhealthgroup, NYSE:UNH , insurance, insuranceclaims, unhinsurance, unhclaims, unhdeductible, unhstock, unhprice, unhtarget, unhsetup, unhtrade, unhzone, medicare, unhanalysis, unitedhealthanalysis, unhtradeidea, unhidea, unhrecentevents,
NYSE:UNHShort
by TonyAiello
UNH Bounce - Don't Miss Out On This 15% OpportunityNYSE:UNH dropped after the tragic death of UnitedHealthcare CEO (not UNH Group CEO) as well as public backlash. Nevertheless, as always in such situation, this has nothing to do with the stock itself. As price action traders we do not trade political or news events since those drops have an unimportant impact mid- to long-term. UNH now sits on the support zone at around $550 which was previous resistance. We also filled the daily gap at around $568 completely. We touched the 0.236 Fib from the $273 bottom (from 2020) and the RSI is nearly oversold on the daily. This gives us a got chance for a bounce from this zone up to $600 - $620. Support Levels: $550 $528 Target/Resistance Levels: $600 $622-628
NYSE:UNHLong
by LGNDRY-Capital
1
UnitedHealth Group ($UNH) Faces Surge in Medical CostsUnitedHealth Group Inc. (NYSE: NYSE:UNH ), one of the largest health insurers in the United States, reported a 3% drop in share price following its Q3 2024 earnings report. The company's results highlighted an uptick in medical costs as it grapples with challenges in its insurance business, including lower government payments and persistently high healthcare demand. Let’s break down the key aspects driving the stock's recent performance. Elevated Costs and Earnings Beat UnitedHealth's Q3 2024 results showed a significant rise in its medical loss ratio (MLR)—the percentage of premiums used to cover medical costs. The MLR rose to 85.2%, exceeding both last year’s figure (82.3%) and analysts’ expectations of 84.2%. This surge in costs is attributed to an increase in healthcare services under Medicare plans, particularly for individuals aged 65 and older, as postponed procedures from the COVID-19 pandemic catch up. Additionally, turnover in Medicaid has left insurers with a sicker patient base, further elevating costs. Despite these challenges, UnitedHealth delivered an adjusted profit of $7.15 per share, beating Wall Street estimates by 15 cents. The company's revenues hit $100.8 billion, surpassing the $99.28 billion expected by analysts, thanks to strong growth in its healthcare services businesses under Optum and insurance offerings under UnitedHealthcare. Key highlights: - Optum Health revenue grew by $2.1 billion, driven by the expansion of value-based care and in-home patient services. - Optum Rx, the company’s pharmacy services division, saw revenue growth of $5.4 billion, fueled by new clients and expanded pharmacy offerings. - Medicare and Medicaid pressures persisted, with the company facing government funding reductions and a sicker Medicaid population due to eligibility redeterminations. While the overall financial performance was positive, the rise in medical costs and increased demand for healthcare services, particularly from Medicare and Medicaid plans, weighed on investor sentiment, contributing to the drop in stock price. Technical Outlook: Bearish Signs Emerge On the technical front, NYSE:UNH stock has entered a bearish trend following the earnings report, and it is currently down 3.54% in Tuesday’s pre-market trading. On Monday, the stock saw a 1.60% gain but quickly reversed as the negative aspects of the earnings report began to dominate market sentiment. The stock has broken below its symmetrical triangle pattern, confirming a bearish continuation pattern. The Relative Strength Index (RSI) was 66 on Monday, indicating the stock was approaching overbought territory. However, the sharp decline in pre-market trading has relieved some of this pressure. If the bearish momentum continues, the RSI could dip below 50, signaling further downside potential. Immediate support lies at $530, the base of the triangle pattern, where the stock may find some consolidation. The stock is currently hovering around its 50-day. A break below these levels could reinforce the bearish sentiment and signal further downside to come. What Can Investors Expect? From a fundamental perspective, UnitedHealth's revenue growth and earnings beat show that the company remains a leader in the healthcare sector, with its Optum businesses continuing to drive profitability. However, the elevated medical costs, particularly related to Medicare and Medicaid, could be a persistent headwind. Regulatory changes or adjustments in Medicaid enrollment could also add to volatility in the coming quarters. On the technical side, the break below the triangle pattern is a bearish signal, and further downside toward the $530 support level seems likely if sentiment does not improve. Investors should watch for signs of consolidation at these levels or a potential breakdown, which could push the stock even lower. Conclusion UnitedHealth Group (NYSE: NYSE:UNH ) remains a strong company with a diverse portfolio spanning insurance and healthcare services. However, its near-term outlook is clouded by rising medical costs, Medicare funding challenges, and Medicaid enrollment fluctuations. Technically, the stock is in a bearish phase, but key support levels could provide opportunities for long-term investors if the stock consolidates or rebounds.
NYSE:UNHShort
by DEXWireNews
UNITED HEALTH forming a bottom.United Health (UNH) gave an excellent dip buy opportunity last time (March 29, see chart below), with the price even breaking above the long-term Resistance Zone eventually: The price has since entered a Channel Up pattern with the price now below its 1D MA50 (blue trend-line), having already topped and attempting to form a new Higher Low at the bottom of the pattern. Like the previous one in June, this bottoming process can take another 3 weeks, so we will time it accordingly and target 675.00 (+21.00% rise, similar to both previous Bullish Legs). ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:UNHLong
by TradingShot
Earnings alert: Companies to watch for potential trades this weeAs we step into the second week of the Q1 earnings season, a roster of major financial players is gearing up to unveil their financial reports. Expect updates from Goldman Sachs, Bank of America, Morgan Stanley, American Express, Blackstone, and Charles Schwab. Additionally, non-financial companies like UnitedHealth, Taiwan Semiconductor Manufacturing, Netflix, P&G, J&J, and ASML Holding are also slated to release their earnings. While bank stocks have been outperforming the broader S&P 500 Index in the past six months, the tide may be turning in the first quarter of this year. Despite JPMorgan's announcement of a modest 6% rise in profits on Friday, shares dropped over 5% following the bank's conservative full-year projections for net interest income. Meanwhile, Wells Fargo and Citigroup saw declines in profits. On Wednesday, eyes will be on Discover Financial Services as it presents its results following the announcement of its acquisition by Capital One in February. And wrapping up the week is American Express, which is set to report after providing strong full-year guidance and increasing its dividend in the last quarter. Blackstone is expected to reveal a year-over-year increase in earnings driven by higher revenues. Thursday brings Netflix's report, with the streaming giant aiming to maintain its momentum in subscriber growth. Netflix's management has recently expressed confidence in their growth strategy, emphasizing improvements across all aspects of their platform, the introduction of paid sharing, and the expansion of their advertising offerings. Consumer product giants Johnson & Johnson and Procter & Gamble will disclose their earnings on Tuesday and Friday respectively, offering insights into whether increased prices are sustaining revenue growth. Meanwhile, health insurer UnitedHealth Group is set to report on Tuesday amid rumors of an antitrust investigation.
SP:SPX
by BlackBull_Markets
UNH UnitedHealth Group Incorporated Options Ahead of EarningsIf you haven`t bought UNH before the previous earnings: Then analyzing the options chain and the chart patterns of UNH UnitedHealth Group Incorporated prior to the earnings report this week, I would consider purchasing the 440usd strike price at the money Puts with an expiration date of 2024-4-19, for a premium of approximately $10.65. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NYSE:UNHShort
by TopgOptions
UNITED HEALTH Time to buy again?Last time we looked into United Health (UNH) we gave a strong buy signal (October 03 2023, see chart below), which turned out to be very successful: After getting rejected on Resistance 3, the stock started to decline structurally within a Channel Down. It is a pattern similar to the Channel Down of November 2022 - March 2023, which was again formed after UNH got rejected within the 2-year Resistance Zone, like it happened this time. There is a high symmetry these past 2 years within the Resistance and Support Zones, so we expect the price to act accordingly. As a result, having already formed a 1D Death Cross, we expect the price to make one last Low towards the Support Zone (as long as the 1D MA50 holds as Resistance) and then rebound, which is what took place on March 10 2023, above the 0.618 Fibonacci retracement level. As a result, we will time our buy accordingly and target $517.00 (Fib 0.618). An additional buy signal would be if the 1W RSI makes a Double Bottom, similar again to March 10 2023. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:UNH
by TradingShot
UNITED HEALTH rebound on 1D MA50 leading to 610 long term.UNH held yesterday the 1D MA50 and is on a strong 1D candle rebound today. Despite this, the 1D technical outlook is on healthy bullish numbers (RSI = 64.198, MACD = 4.620, ADX = 38.658) as the underlying pattern is a Channel Up since the July 13th low. The stock's most common rise extension is inside the 15.32-15.96% range, which we've seen three times in the last eight months. Consequently we aim at the +15.32% minimum (TP = 610.00). ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NYSE:UNHLong
by InvestingScope
UnitedHealth: Last hurdle 🚧Although UnitedHealth shares were able to establish the low of the turquoise wave 4 and rise steadily, they have not yet made it above the resistance level of $546.78. However, we expect this to happen next, leading to the high of the larger wave (A) in dark green. Short-term, we therefore expect further bullish potential, but after the top of this (A) wave, the trend should be clearly downwards again. In addition, there is a 35% probability for our alternative scenario, in which the alternative top of the old wave (A) would have already been deposited.
NYSE:UNHLong
by MarketIntel
UNITED HEALTH Buy signal to complete the Cup pattern.United Health is on a green (1w) candle despite the general market sell-off. This is technically due to the longer term pattern which is shaping up to be a Cup/ Arc, that remains to be seen if at the end of it will give a Handle. Trading Plan: 1. Buy on the current market price. Targets: 1. 553.00 (bottom of Resistance Zone 1 which was initially formed on April 11th 2022). Tips: 1. The MACD (1d) is rising with a Bullish Cross last seen in July and despite being bullish over 0.00, it is still underpriced. Please like, follow and comment!!
NYSE:UNHLong
by TradingBrokersView
UNH UnitedHealth Group Incorporated Options Ahead of EarningsIf you haven`t sold UNH`s Double Top here: or reentered the Double Bottom: Then analyzing the options chain and the chart patterns of UNH UnitedHealth Group Incorporated prior to the earnings report this week, I would consider purchasing the 530usd strike price Calls with an expiration date of 2023-10-13, for a premium of approximately $6.40. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:UNHLong
by TopgOptions
UNITED HEALTH Mega bullish break-out. ATH next.United Health Group Incorporated (UNH) broke above the Lower Highs trend-line that has been holding since the October 31 2022 All Time High (ATH). That is a major bullish break-out signal alone but has one last short-term Resistance to overcome, Resistance 1 (516.00) which happens to be exactly on the 0.618 Fibonacci retracement level. If that Resistance level breaks, we will buy and target Resistance 2 (530.65). Then even though the bullish leg might extend higher, we will only buy after a clear pull-back to the 0.618 Fibonacci and target the ATH (558.00) that happens to be just above Resistance 3. The Lower Highs bullish break-out signal is strengthened by the fact that the RSI on the 1W time-frame is coming off a Bullish Divergence. On such long tern downtrends, this typically signifies a strong bullish reversal. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:UNHLong
by TradingShot
UNH UnitedHealth Group Incorporated Options Ahead of EarningsIf you haven`t sold UNH here: or here: Then analyzing the options chain of UNH UnitedHealth Group Incorporated prior to the earnings report this week, I would consider purchasing the 460usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $36.25. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:UNHLong
by TopgOptions
5
UNITED HEALTH On the 1D MA50 but only buy under this condition.United Health is having an incredible price jump today with the price hitting the 1D MA50 for the first time in one month and the 1D timeframe attempting to get out of its neutrality (RSI = 52.965, MACD = -5.780, ADX = 33.018). This state shows that we don't have a confirmed buy signal yet, that will only come if the 1D candle closes over the 1D MA50. If not, a pull back to the bottom of the ten month Channel Down. The 1D RSI is also inside a Channel Down, a breakout there would also be a buy signal. So if the candle closes above the 1D MA50 we will buy and aim at the top of the Channel Down (TP = 512.50) expecting the whole rally to complete a +15% rise. If rejected we will buy near the bottom of the Channel Down and target again its top near the 0.786 Fibonacci leve (TP = 508.00). That is where the previous LH was formed. ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NYSE:UNH
by InvestingScope
10
United Health Earnings BeatOn Friday 14th April 2023 UnitedHealth Group reported full year and fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare. Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Cash Flows from Operations were $26.2 Billion or 1.3x Net Income Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of HKEX:357 billion to HKEX:360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of HKEX:27 billion to HKEX:28 billion.
NYSE:UNHLong
by BenSparham
United Health: Healthy As A… Bear? 🐻… or what was that saying again? Anyway, after a short hiatus, the bears in our United Health-chart should regain their health and get back to work. They should soon push the share below the support at $456.73 and from there into the dark green zone between $427.67 and $391.43, where wave A in dark green should end. This low should then be followed by a considerable upwards movement above the resistance at $501.40. There is also a 37% chance that United Health could cold-shoulder the dark green zone and climb above $501.40 directly. In that case, we would consider wave alt.A in dark green to be already finished.
NYSE:UNH
by MarketIntel